Trials / Unknown
UnknownNCT05252741
Levels of Pigment Epithelium-derived Factor in Patients With Psoriasis.
Evaluation Of Levels Of Pigment Epithelium-Derived Factor (PEDF) In Patients With Psoriasis.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Psoriasis is an immune-mediated chronic inflammatory skin disease associated with increase interaction of inflammatory mediators like adipokines. Pigment epithelium-derived factor (PEDF) is one of the most abundant adipokines and have anti-angiogenesis effect. There is a study showed that PEDF level is up-regulated in the sera of psoriasis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | serum samples and punch skin biopsies | we will take serum samples from psoriasis patients and healthy controls and skin punch biopsies from lesional and non-lesional areas in psoriasis patients. |
Timeline
- Start date
- 2022-02-20
- Primary completion
- 2023-02-01
- Completion
- 2023-09-01
- First posted
- 2022-02-23
- Last updated
- 2022-04-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05252741. Inclusion in this directory is not an endorsement.